PTC Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
28.10.25
/
50%
€57.50
Target price
28.10.26
-
Performance (%)
18.61%
Price
16.07.26
€68.20
Summary
This prediction is currently active. The prediction currently has a performance of 18.61%. This prediction currently runs until 28.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -13.776% | -13.776% |
| iShares Core DAX® | -1,09 % | 0,20 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % |
| iShares S&P 500 | -0,20 % | 1,77 % |
Comments by Jefferies_Financial_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics (NASDAQ:PTCT) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€60.76
27.05.26
27.05.26
€73.02
27.05.27
27.05.27
13.00%
16.07.26
16.07.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.60
20.05.24
20.05.24
€42.34
20.05.25
20.05.25
10.38%
21.05.25
21.05.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.60
21.03.24
21.03.24
€32.14
21.03.25
21.03.25
92.03%
22.03.25
22.03.25